Literature DB >> 19116450

Curcuminoid-phospholipid complex induces apoptosis in mammary epithelial cells by STAT-3 signaling.

Laura Starvaggi Cucuzza1, Massimiliano Motta, Silvia Miretti, Paolo Accornero, Mario Baratta.   

Abstract

Curcumin (from the rhizome of Curcuma longa) is well documented for its medicinal properties in Indian and Chinese systems of medicine where it is widely used for the treatment of several diseases. Epidemiological observations are suggestive that curcumin consumption may reduce the risk of some form of cancers and provide other protective biological effects in humans. These biological properties have been attributed to curcuminoids that have been widely studied for their anti-inflammatory, anti-angiogenic, antioxidant, wound healing and anti-cancer effects. In this study we have investigated on the effect of a curcumin phospholipid complex on mammary epithelial cell viability. HC11 and BME-UV cell lines, validated models to study biology of normal, not tumoral, mammary epithelial cells, were used to analyse these effects. We report that curcumin acts on STAT-3 signal pathway to reduce cell viability and increase apoptosis evaluated by the the amount of activated caspase 3. Further it reduces MAPK and AKT activations. JSI-124, a STAT-3 inhibitor (100 nM) was able to block the negative effect of curcumin on cell viability and caspase 3 activation. Finally the negative effect of cucumin on cell viability has been impaired in STAT-3i HC11, where STAT-3 protein was greatly reduced by shRNA-interference. These results indicate that curcumin presents a potential adverse effect to normal mammary epithelial cells and that it has a specific effect on signal trasduction in mammary epithelium.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19116450      PMCID: PMC2679335          DOI: 10.3858/emm.2008.40.6.647

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  40 in total

1.  Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.

Authors:  Tin Lap Lee; Jason Yeh; Carter Van Waes; Zhong Chen
Journal:  Mol Cancer Ther       Date:  2006-01       Impact factor: 6.261

Review 2.  Multiple biological activities of curcumin: a short review.

Authors:  Radha K Maheshwari; Anoop K Singh; Jaya Gaddipati; Rikhab C Srimal
Journal:  Life Sci       Date:  2006-01-18       Impact factor: 5.037

3.  Mechanisms of curcumin- and EGF-receptor related protein (ERRP)-dependent growth inhibition of colon cancer cells.

Authors:  Sudha Reddy; Arun K Rishi; Hu Xu; Edi Levi; Fazlul H Sarkar; Adhip P N Majumdar
Journal:  Nutr Cancer       Date:  2006       Impact factor: 2.900

Review 4.  Inhibitory effects of curcumin on tumorigenesis in mice.

Authors:  M T Huang; H L Newmark; K Frenkel
Journal:  J Cell Biochem Suppl       Date:  1997

Review 5.  The c-Myc target gene network.

Authors:  Chi V Dang; Kathryn A O'Donnell; Karen I Zeller; Tam Nguyen; Rebecca C Osthus; Feng Li
Journal:  Semin Cancer Biol       Date:  2006-07-25       Impact factor: 15.707

6.  [Antitumor effect and apoptosis induction in human cancer cell lines by BRM-SJS].

Authors:  Zhao-Yang Liu; Ze-Guang Wang; Xing-Jing Liu; Hai-Mei Tian; Di-Ya Na; Yi-Fei Zhang; Wei Zhang
Journal:  Ai Zheng       Date:  2004-11

7.  Activation of p70S6K induces expression of matrix metalloproteinase 9 associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells.

Authors:  Hong Y Zhou; Alice S T Wong
Journal:  Endocrinology       Date:  2006-02-09       Impact factor: 4.736

8.  Potential anticancer activity of turmeric (Curcuma longa).

Authors:  R Kuttan; P Bhanumathy; K Nirmala; M C George
Journal:  Cancer Lett       Date:  1985-11       Impact factor: 8.679

9.  Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells.

Authors:  Manik Chatterjee; Thorsten Stühmer; Pia Herrmann; Kurt Bommert; Bernd Dörken; Ralf C Bargou
Journal:  Blood       Date:  2004-08-05       Impact factor: 22.113

10.  RNAi technology and lentiviral delivery as a powerful tool to suppress Tpr-Met-mediated tumorigenesis.

Authors:  Riccardo Taulli; Paolo Accornero; Antonia Follenzi; Tony Mangano; Alessandro Morotti; Claudio Scuoppo; Paolo E Forni; Francesca Bersani; Tiziana Crepaldi; Roberto Chiarle; Luigi Naldini; Carola Ponzetto
Journal:  Cancer Gene Ther       Date:  2005-05       Impact factor: 5.987

View more
  3 in total

Review 1.  Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?

Authors:  Jayaraj Ravindran; Sahdeo Prasad; Bharat B Aggarwal
Journal:  AAPS J       Date:  2009-07-10       Impact factor: 4.009

2.  Curcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatment.

Authors:  Marie-Hélène Teiten; Serge Eifes; Mario Dicato; Marc Diederich
Journal:  Toxins (Basel)       Date:  2010-01-21       Impact factor: 4.546

Review 3.  Curcumin and Osteosarcoma: Can Invertible Polymeric Micelles Help?

Authors:  Avudaiappan Maran; Michael J Yaszemski; Ananiy Kohut; Andriy Voronov
Journal:  Materials (Basel)       Date:  2016-06-27       Impact factor: 3.623

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.